UBS Group
BBOT

UBS Group’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

UBS Group’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$728K Sell
68,534
-24,126
-26% -$256K ﹤0.01% 4573
2025
Q1 		$1.05M Buy
92,660
+57,712
+165% +$652K ﹤0.01% 4169
2024
Q4 		$367K Buy
34,948
+34,927
+166,319% +$367K ﹤0.01% 4893
2024
Q3 		$219 Buy
+21
New +$219 ﹤0.01% 7837